Tweet
Does Anybody has the experience of mate pair sequence? Except the insert size is different from pair end sequence, and what is the benefit with this method? 
-
Last edited by Chien-Yuan Chen; 03-01-2009, 01:25 PM. -
Never tried mate pair myself. Only used PE so far.
Straight from Illumina: http://investor.illumina.com/phoenix...574&highlight=
Check this website that talks of mate pair (MP) libraries: http://seq.molbiol.ru/#i_c_fr
This older thread might also help clarify some things: http://seqanswers.com/forums/showthread.php?t=503
Hope that helps. -
Illumina's regular "paired end" kits can do an insert size around 500 bp.
Their first "mate pair" kits use a different technique, and can do much longer insert sizes. I understand 4 kbp kits are available, and 10 kbp kits will be available soon.
The BENEFIT of longer insert size comes when trying to assemble sequences. It is IMPOSSIBLE to resolve a repeated sequence of length N unless you have paired end reads with an insert size of at least size N. As many common repeats in genomes are usually much larger than 500 bp, the "mate pair" kits are crucial to resolving these repeats and finishing/closing genomes (or at least drastically reducing the number of contigs).Comment
-
Is it correct that: PE is used for SNP/indel detection and ME for structural variation. Both can be used for de novo assembly?Comment
-
Yes it is true, but not quite the full truth.Originally posted by bair View Post
ANY reads can be used for SNP/indel coverage - that includes short reads, long reads, paired-end reads, single-end reads, mate-pair reads - it doesn't matter, as long as there is sufficient coverage and/or quality to infer a statistically signficant result.
For structural variation, yes of course you need to be able to examine large scale sequence relationships, and PE or SE reads will not do this beyond ~500 bp say. Large insert libraries such as MP and 454FLX are needed here. Or other strategies such as Opgen's "optical mapping" maps.
De novo assembly can use any reads you give it, including SE, PE, and MP. The ability of different software to handle mixes of these data types varies however.Comment
-
Thank you Torst,
In order to get "robust" SNPs/indel, it might be better to use PE / ME to confirm SNPs by two directions, but I did not see SNPs detection programs doing things like this way. Maybe I'm wrong.Comment
-
Mate pair reads are essential (or at least extremely helpful) in de novo projects for orienting contigs into scaffolds. However you shouldn't use mate pair libraries as your source for general coverage. Illumina recommends reads no longer than 36nt when sequencing mate pair libraries; this is to reduce the probability of a read crossing the junction point where the two distant ends of the original DNA fragment were joined during circularization. To generate the bulk of your coverage it is best to use 2x100 (or 2x120) paired end reads. Secondly, the method used to generate mate paired libraries requires a lot of DNA and ends up "throwing away" most of it. This has implications for library diversity.Originally posted by bair View PostComment
-
You are still thinking in old "Sanger sequencing" terms. High throughput sequencing produces coverage depths of 50 to 500 fold! About half the reads will be "forward" and half "reverse". The statistical significance of SNPs at this coverage is high.Originally posted by bair View PostComment
-
I agree with this mostly. The MP protocol has issue with (1) chimeras, (2) pollution with fragments not including the junction, which end up like PE reads, and (3) the 10x amount of DNA required. If you can do a MP and a PE run as kmcarr describes, you get the benefit of large scale scaffold information from the MP, and the finer depth and detail of the PE.Originally posted by kmcarr View PostComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment